Vanda Pharmaceuticals OverviewVanda Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for VNDA.
Quarterly Other Income/Expense
$1.80M
↓ 50.82% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$8.31M
↓ 50.62% YoY
Trailing 12 months ending Mar 31, 2026